Ultragenyx Pharmaceutical, Inc. (RARE)
21.69
-0.13
(-0.60%)
USD |
NASDAQ |
Mar 17, 15:05
Ultragenyx Pharmaceutical Market Cap : 2.096B for March 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.532B |
| Johnson & Johnson | 576.30B |
| CorMedix, Inc. | 514.22M |
| BioMarin Pharmaceutical, Inc. | 11.00B |
| Insmed, Inc. | 31.55B |
Market Cap Related Metrics
| PS Ratio | 3.179 |
| Price | 21.69 |
| Earnings Yield | -26.91% |